Wells Fargo & Company Karyopharm Therapeutics Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 666 shares of KPTI stock, worth $466. This represents 0.0% of its overall portfolio holdings.

Number of Shares
666
Previous 14 4657.14%
Holding current value
$466
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.7 - $1.06 $456 - $691
652 Added 4657.14%
666 $0
Q2 2024

Aug 13, 2024
SELL
$0.87 - $1.58 $29,479 - $53,536
-33,884 Reduced 99.96%
14 $0
Q1 2024

May 10, 2024
BUY
$0.72 - $1.66 $3,263 - $7,524
4,533 Added 15.44%
33,898 $51,000
Q4 2023

Feb 09, 2024
BUY
$0.68 - $1.31 $4,543 - $8,753
6,682 Added 29.46%
29,365 $25,000
Q3 2023

Nov 13, 2023
SELL
$1.14 - $1.81 $27,968 - $44,406
-24,534 Reduced 51.96%
22,683 $30,000
Q2 2023

Aug 15, 2023
SELL
$1.79 - $4.59 $215,558 - $552,746
-120,424 Reduced 71.83%
47,217 $84,000
Q1 2023

May 12, 2023
BUY
$2.84 - $3.92 $475,753 - $656,674
167,519 Added 137310.66%
167,641 $652,000
Q4 2022

Feb 13, 2023
SELL
$2.48 - $5.93 $13,704 - $32,769
-5,526 Reduced 97.84%
122 $0
Q3 2022

Nov 14, 2022
SELL
$4.08 - $5.82 $4,908 - $7,001
-1,203 Reduced 17.56%
5,648 $30,000
Q2 2022

Aug 12, 2022
SELL
$4.15 - $8.37 $141,203 - $284,789
-34,025 Reduced 83.24%
6,851 $31,000
Q1 2022

May 16, 2022
SELL
$5.91 - $14.38 $147,702 - $359,384
-24,992 Reduced 37.94%
40,876 $302,000
Q4 2021

Feb 14, 2022
BUY
$5.21 - $8.61 $210,890 - $348,515
40,478 Added 159.42%
65,868 $424,000
Q3 2021

Nov 15, 2021
SELL
$4.45 - $10.63 $23,433 - $55,977
-5,266 Reduced 17.18%
25,390 $148,000
Q2 2021

Aug 16, 2021
SELL
$8.11 - $11.11 $599,507 - $821,273
-73,922 Reduced 70.69%
30,656 $316,000
Q1 2021

May 13, 2021
SELL
$9.85 - $17.69 $555,983 - $998,512
-56,445 Reduced 35.05%
104,578 $1.1 Million
Q4 2020

Feb 09, 2021
SELL
$14.15 - $17.19 $254,487 - $309,162
-17,985 Reduced 10.05%
161,023 $2.49 Million
Q3 2020

Nov 05, 2020
SELL
$14.14 - $19.71 $25,254 - $35,202
-1,786 Reduced 0.99%
179,008 $2.61 Million
Q2 2020

Aug 13, 2020
BUY
$16.6 - $25.25 $1.95 Million - $2.96 Million
117,385 Added 185.12%
180,794 $3.43 Million
Q1 2020

May 14, 2020
BUY
$14.38 - $27.72 $911,821 - $1.76 Million
63,409 New
63,409 $1.22 Million

Others Institutions Holding KPTI

# of Institutions
98
Shares Held
57.6M
Call Options Held
258K
Put Options Held
81.2K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $55.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email